SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001181431-12-032858
Filing Date
2012-05-25
Accepted
2012-05-25 16:54:52
Documents
1
Period of Report
2012-05-25
Filing Date Changed
2012-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd346893.html 4  
1 FORM 4 rrd346893.xml 4 2901
  Complete submission text file 0001181431-12-032858.txt   4313
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 7 WELLS AVENUE NEWTON MA 02459
Business Address
Martin Rod D (Reporting) CIK: 0001456614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 12871961